Copyright Reports & Markets. All rights reserved.

Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Market Report 2021

Request for Sample of this report
Buy now

1 Direct-to-consumer Disease Risk and Health Genetic Test Market Overview

  • 1.1 Direct-to-consumer Disease Risk and Health Genetic Test Product Scope
  • 1.2 Direct-to-consumer Disease Risk and Health Genetic Test Segment by Type
    • 1.2.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Celiac Disease
    • 1.2.3 Parkinson Disease
    • 1.2.4 Alzheimer Disease
    • 1.2.5 Other
  • 1.3 Direct-to-consumer Disease Risk and Health Genetic Test Segment by Application
    • 1.3.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Online
    • 1.3.3 Offline
  • 1.4 Direct-to-consumer Disease Risk and Health Genetic Test Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Direct-to-consumer Disease Risk and Health Genetic Test Price Trends (2016-2027)

2 Direct-to-consumer Disease Risk and Health Genetic Test Estimates and Forecasts by Region

  • 2.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue Market Share by Region (2016-2021)
  • 2.3 Global Direct-to-consumer Disease Risk and Health Genetic Test Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Direct-to-consumer Disease Risk and Health Genetic Test Estimates and Projections (2016-2027)
    • 2.4.2 Europe Direct-to-consumer Disease Risk and Health Genetic Test Estimates and Projections (2016-2027)
    • 2.4.3 China Direct-to-consumer Disease Risk and Health Genetic Test Estimates and Projections (2016-2027)
    • 2.4.4 Japan Direct-to-consumer Disease Risk and Health Genetic Test Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Direct-to-consumer Disease Risk and Health Genetic Test Estimates and Projections (2016-2027)
    • 2.4.6 India Direct-to-consumer Disease Risk and Health Genetic Test Estimates and Projections (2016-2027)

3 Global Direct-to-consumer Disease Risk and Health Genetic Test Competition Landscape by Players

  • 3.1 Global Top Direct-to-consumer Disease Risk and Health Genetic Test Players by Sales (2016-2021)
  • 3.2 Global Top Direct-to-consumer Disease Risk and Health Genetic Test Players by Revenue (2016-2021)
  • 3.3 Global Direct-to-consumer Disease Risk and Health Genetic Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Direct-to-consumer Disease Risk and Health Genetic Test as of 2020)
  • 3.4 Global Direct-to-consumer Disease Risk and Health Genetic Test Average Price by Company (2016-2021)
  • 3.5 Manufacturers Direct-to-consumer Disease Risk and Health Genetic Test Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Direct-to-consumer Disease Risk and Health Genetic Test Market Size by Type

  • 4.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Direct-to-consumer Disease Risk and Health Genetic Test Price by Type (2016-2021)
  • 4.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Direct-to-consumer Disease Risk and Health Genetic Test Price Forecast by Type (2022-2027)

5 Global Direct-to-consumer Disease Risk and Health Genetic Test Market Size by Application

  • 5.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Direct-to-consumer Disease Risk and Health Genetic Test Price by Application (2016-2021)
  • 5.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Direct-to-consumer Disease Risk and Health Genetic Test Price Forecast by Application (2022-2027)

6 North America Direct-to-consumer Disease Risk and Health Genetic Test Market Facts & Figures

  • 6.1 North America Direct-to-consumer Disease Risk and Health Genetic Test Sales by Company
    • 6.1.1 North America Direct-to-consumer Disease Risk and Health Genetic Test Sales by Company (2016-2021)
    • 6.1.2 North America Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Company (2016-2021)
  • 6.2 North America Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Type
    • 6.2.1 North America Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Type (2022-2027)
  • 6.3 North America Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Application
    • 6.3.1 North America Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Application (2022-2027)

7 Europe Direct-to-consumer Disease Risk and Health Genetic Test Market Facts & Figures

  • 7.1 Europe Direct-to-consumer Disease Risk and Health Genetic Test Sales by Company
    • 7.1.1 Europe Direct-to-consumer Disease Risk and Health Genetic Test Sales by Company (2016-2021)
    • 7.1.2 Europe Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Company (2016-2021)
  • 7.2 Europe Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Type
    • 7.2.1 Europe Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Application
    • 7.3.1 Europe 146 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 146 Sales Breakdown by Application (2022-2027)

8 China Direct-to-consumer Disease Risk and Health Genetic Test Market Facts & Figures

  • 8.1 China Direct-to-consumer Disease Risk and Health Genetic Test Sales by Company
    • 8.1.1 China Direct-to-consumer Disease Risk and Health Genetic Test Sales by Company (2016-2021)
    • 8.1.2 China Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Company (2016-2021)
  • 8.2 China Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Type
    • 8.2.1 China Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Type (2022-2027)
  • 8.3 China Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Application
    • 8.3.1 China 316 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 316 Sales Breakdown by Application (2022-2027)

9 Japan Direct-to-consumer Disease Risk and Health Genetic Test Market Facts & Figures

  • 9.1 Japan Direct-to-consumer Disease Risk and Health Genetic Test Sales by Company
    • 9.1.1 Japan Direct-to-consumer Disease Risk and Health Genetic Test Sales by Company (2016-2021)
    • 9.1.2 Japan Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Company (2016-2021)
  • 9.2 Japan Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Type
    • 9.2.1 Japan Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Direct-to-consumer Disease Risk and Health Genetic Test Market Facts & Figures

  • 10.1 Southeast Asia Direct-to-consumer Disease Risk and Health Genetic Test Sales by Company
    • 10.1.1 Southeast Asia Direct-to-consumer Disease Risk and Health Genetic Test Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Type
    • 10.2.1 Southeast Asia Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Direct-to-consumer Disease Risk and Health Genetic Test Market Facts & Figures

  • 11.1 India Direct-to-consumer Disease Risk and Health Genetic Test Sales by Company
    • 11.1.1 India Direct-to-consumer Disease Risk and Health Genetic Test Sales by Company (2016-2021)
    • 11.1.2 India Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Company (2016-2021)
  • 11.2 India Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Type
    • 11.2.1 India Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Type (2022-2027)
  • 11.3 India Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Application
    • 11.3.1 India Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Direct-to-consumer Disease Risk and Health Genetic Test Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Direct-to-consumer Disease Risk and Health Genetic Test Business

  • 12.1 23andMe
    • 12.1.1 23andMe Corporation Information
    • 12.1.2 23andMe Business Overview
    • 12.1.3 23andMe Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 23andMe Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.1.5 23andMe Recent Development
  • 12.2 MyHeritage
    • 12.2.1 MyHeritage Corporation Information
    • 12.2.2 MyHeritage Business Overview
    • 12.2.3 MyHeritage Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 MyHeritage Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.2.5 MyHeritage Recent Development
  • 12.3 LabCorp
    • 12.3.1 LabCorp Corporation Information
    • 12.3.2 LabCorp Business Overview
    • 12.3.3 LabCorp Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 LabCorp Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.3.5 LabCorp Recent Development
  • 12.4 Myriad Genetics
    • 12.4.1 Myriad Genetics Corporation Information
    • 12.4.2 Myriad Genetics Business Overview
    • 12.4.3 Myriad Genetics Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Myriad Genetics Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.4.5 Myriad Genetics Recent Development
  • 12.5 Ancestry.com
    • 12.5.1 Ancestry.com Corporation Information
    • 12.5.2 Ancestry.com Business Overview
    • 12.5.3 Ancestry.com Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Ancestry.com Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.5.5 Ancestry.com Recent Development
  • 12.6 Quest Diagnostics
    • 12.6.1 Quest Diagnostics Corporation Information
    • 12.6.2 Quest Diagnostics Business Overview
    • 12.6.3 Quest Diagnostics Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Quest Diagnostics Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.6.5 Quest Diagnostics Recent Development
  • 12.7 Gene By Gene
    • 12.7.1 Gene By Gene Corporation Information
    • 12.7.2 Gene By Gene Business Overview
    • 12.7.3 Gene By Gene Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Gene By Gene Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.7.5 Gene By Gene Recent Development
  • 12.8 DNA Diagnostics Center
    • 12.8.1 DNA Diagnostics Center Corporation Information
    • 12.8.2 DNA Diagnostics Center Business Overview
    • 12.8.3 DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.8.5 DNA Diagnostics Center Recent Development
  • 12.9 Invitae
    • 12.9.1 Invitae Corporation Information
    • 12.9.2 Invitae Business Overview
    • 12.9.3 Invitae Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Invitae Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.9.5 Invitae Recent Development
  • 12.10 IntelliGenetics
    • 12.10.1 IntelliGenetics Corporation Information
    • 12.10.2 IntelliGenetics Business Overview
    • 12.10.3 IntelliGenetics Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 IntelliGenetics Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.10.5 IntelliGenetics Recent Development
  • 12.11 Ambry Genetics
    • 12.11.1 Ambry Genetics Corporation Information
    • 12.11.2 Ambry Genetics Business Overview
    • 12.11.3 Ambry Genetics Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 Ambry Genetics Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.11.5 Ambry Genetics Recent Development
  • 12.12 Living DNA
    • 12.12.1 Living DNA Corporation Information
    • 12.12.2 Living DNA Business Overview
    • 12.12.3 Living DNA Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Living DNA Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.12.5 Living DNA Recent Development
  • 12.13 EasyDNA
    • 12.13.1 EasyDNA Corporation Information
    • 12.13.2 EasyDNA Business Overview
    • 12.13.3 EasyDNA Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 EasyDNA Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.13.5 EasyDNA Recent Development
  • 12.14 Pathway Genomics
    • 12.14.1 Pathway Genomics Corporation Information
    • 12.14.2 Pathway Genomics Business Overview
    • 12.14.3 Pathway Genomics Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.14.4 Pathway Genomics Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.14.5 Pathway Genomics Recent Development
  • 12.15 Centrillion Technology
    • 12.15.1 Centrillion Technology Corporation Information
    • 12.15.2 Centrillion Technology Business Overview
    • 12.15.3 Centrillion Technology Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.15.4 Centrillion Technology Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.15.5 Centrillion Technology Recent Development
  • 12.16 Xcode
    • 12.16.1 Xcode Corporation Information
    • 12.16.2 Xcode Business Overview
    • 12.16.3 Xcode Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.16.4 Xcode Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.16.5 Xcode Recent Development
  • 12.17 Color Genomics
    • 12.17.1 Color Genomics Corporation Information
    • 12.17.2 Color Genomics Business Overview
    • 12.17.3 Color Genomics Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.17.4 Color Genomics Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.17.5 Color Genomics Recent Development
  • 12.18 Anglia DNA Services
    • 12.18.1 Anglia DNA Services Corporation Information
    • 12.18.2 Anglia DNA Services Business Overview
    • 12.18.3 Anglia DNA Services Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.18.4 Anglia DNA Services Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.18.5 Anglia DNA Services Recent Development
  • 12.19 African Ancestry
    • 12.19.1 African Ancestry Corporation Information
    • 12.19.2 African Ancestry Business Overview
    • 12.19.3 African Ancestry Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.19.4 African Ancestry Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.19.5 African Ancestry Recent Development
  • 12.20 Canadian DNA Services
    • 12.20.1 Canadian DNA Services Corporation Information
    • 12.20.2 Canadian DNA Services Business Overview
    • 12.20.3 Canadian DNA Services Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.20.4 Canadian DNA Services Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.20.5 Canadian DNA Services Recent Development
  • 12.21 DNA Family Check
    • 12.21.1 DNA Family Check Corporation Information
    • 12.21.2 DNA Family Check Business Overview
    • 12.21.3 DNA Family Check Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.21.4 DNA Family Check Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.21.5 DNA Family Check Recent Development
  • 12.22 Alpha Biolaboratories
    • 12.22.1 Alpha Biolaboratories Corporation Information
    • 12.22.2 Alpha Biolaboratories Business Overview
    • 12.22.3 Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.22.4 Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.22.5 Alpha Biolaboratories Recent Development
  • 12.23 Test Me DNA
    • 12.23.1 Test Me DNA Corporation Information
    • 12.23.2 Test Me DNA Business Overview
    • 12.23.3 Test Me DNA Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.23.4 Test Me DNA Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.23.5 Test Me DNA Recent Development
  • 12.24 23 Mofang
    • 12.24.1 23 Mofang Corporation Information
    • 12.24.2 23 Mofang Business Overview
    • 12.24.3 23 Mofang Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.24.4 23 Mofang Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.24.5 23 Mofang Recent Development
  • 12.25 Genetic Health
    • 12.25.1 Genetic Health Corporation Information
    • 12.25.2 Genetic Health Business Overview
    • 12.25.3 Genetic Health Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.25.4 Genetic Health Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.25.5 Genetic Health Recent Development
  • 12.26 DNA Services of America
    • 12.26.1 DNA Services of America Corporation Information
    • 12.26.2 DNA Services of America Business Overview
    • 12.26.3 DNA Services of America Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.26.4 DNA Services of America Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.26.5 DNA Services of America Recent Development
  • 12.27 Shuwen Health Sciences
    • 12.27.1 Shuwen Health Sciences Corporation Information
    • 12.27.2 Shuwen Health Sciences Business Overview
    • 12.27.3 Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.27.4 Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.27.5 Shuwen Health Sciences Recent Development
  • 12.28 Mapmygenome
    • 12.28.1 Mapmygenome Corporation Information
    • 12.28.2 Mapmygenome Business Overview
    • 12.28.3 Mapmygenome Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.28.4 Mapmygenome Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.28.5 Mapmygenome Recent Development
  • 12.29 Full Genomes
    • 12.29.1 Full Genomes Corporation Information
    • 12.29.2 Full Genomes Business Overview
    • 12.29.3 Full Genomes Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2016-2021)
    • 12.29.4 Full Genomes Direct-to-consumer Disease Risk and Health Genetic Test Products Offered
    • 12.29.5 Full Genomes Recent Development

13 Direct-to-consumer Disease Risk and Health Genetic Test Manufacturing Cost Analysis

  • 13.1 Direct-to-consumer Disease Risk and Health Genetic Test Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Direct-to-consumer Disease Risk and Health Genetic Test
  • 13.4 Direct-to-consumer Disease Risk and Health Genetic Test Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Direct-to-consumer Disease Risk and Health Genetic Test Distributors List
  • 14.3 Direct-to-consumer Disease Risk and Health Genetic Test Customers

15 Market Dynamics

  • 15.1 Direct-to-consumer Disease Risk and Health Genetic Test Market Trends
  • 15.2 Direct-to-consumer Disease Risk and Health Genetic Test Drivers
  • 15.3 Direct-to-consumer Disease Risk and Health Genetic Test Market Challenges
  • 15.4 Direct-to-consumer Disease Risk and Health Genetic Test Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global Direct-to-consumer Disease Risk and Health Genetic Test market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Direct-to-consumer Disease Risk and Health Genetic Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    Celiac Disease
    Parkinson Disease
    Alzheimer Disease
    Other

    Segment by Application
    Online
    Offline

    The Direct-to-consumer Disease Risk and Health Genetic Test market is analysed and market size information is provided by regions (countries). Segment by Application, the Direct-to-consumer Disease Risk and Health Genetic Test market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    23andMe
    MyHeritage
    LabCorp
    Myriad Genetics
    Ancestry.com
    Quest Diagnostics
    Gene By Gene
    DNA Diagnostics Center
    Invitae
    IntelliGenetics
    Ambry Genetics
    Living DNA
    EasyDNA
    Pathway Genomics
    Centrillion Technology
    Xcode
    Color Genomics
    Anglia DNA Services
    African Ancestry
    Canadian DNA Services
    DNA Family Check
    Alpha Biolaboratories
    Test Me DNA
    23 Mofang
    Genetic Health
    DNA Services of America
    Shuwen Health Sciences
    Mapmygenome
    Full Genomes

    Buy now